Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann E Tollefson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Antiviral Research|August 23, 2017
Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compoundsKaroly Toth, Ann E Tollefson, Jacqueline F Spencer, et al.
Virus Research|February 1, 2005
Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent miceKaroly Toth, Konstantin Doronin, Mohan Kuppuswamy, et al.
Journal of Virology|October 22, 2002
Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosisDrew L Lichtenstein, Peter Krajcsi, David J Esteban, et al.
Virology|February 8, 2003
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirusKonstantin Doronin, Karoly Toth, Mohan Kuppuswamy, et al.
Journal of Virology|October 15, 2003
Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptorTom A Zanardi, Soonpin Yei, Drew L Lichtenstein, et al.
Journal of Virology|October 28, 2004
Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2Drew L Lichtenstein, Konstantin Doronin, Karoly Toth, et al.
Antiviral Research|June 28, 2025
LAVR-289, a broad-spectrum antiviral, protects immunosuppressed Syrian hamsters against lethal adenovirus challengeAnn E Tollefson, Anna Cline-Smith, Vincent Roy, et al.
Journal of Virology|March 3, 2017
Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5Ann E Tollefson, Baoling Ying, Jacqueline F Spencer, et al.
Bioorganic & Medicinal Chemistry|November 16, 2023
Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships explorationHeng Zhang, Jing Li, Karoly Toth, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2024
NPP-669, a prodrug of cidofovir, is highly efficacious against human adenovirus infection in the permissive Syrian hamster modelAnn E Tollefson, Anna B Cline-Smith, Jacqueline F Spencer, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Antiviral Research|August 23, 2017
Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compoundsKaroly Toth, Ann E Tollefson, Jacqueline F Spencer, et al.
Virus Research|February 1, 2005
Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent miceKaroly Toth, Konstantin Doronin, Mohan Kuppuswamy, et al.
Journal of Virology|October 22, 2002
Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosisDrew L Lichtenstein, Peter Krajcsi, David J Esteban, et al.
Virology|February 8, 2003
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirusKonstantin Doronin, Karoly Toth, Mohan Kuppuswamy, et al.
Journal of Virology|October 15, 2003
Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptorTom A Zanardi, Soonpin Yei, Drew L Lichtenstein, et al.
Journal of Virology|October 28, 2004
Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2Drew L Lichtenstein, Konstantin Doronin, Karoly Toth, et al.
Antiviral Research|June 28, 2025
LAVR-289, a broad-spectrum antiviral, protects immunosuppressed Syrian hamsters against lethal adenovirus challengeAnn E Tollefson, Anna Cline-Smith, Vincent Roy, et al.
Journal of Virology|March 3, 2017
Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5Ann E Tollefson, Baoling Ying, Jacqueline F Spencer, et al.
Bioorganic & Medicinal Chemistry|November 16, 2023
Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships explorationHeng Zhang, Jing Li, Karoly Toth, et al.
Antimicrobial Agents and Chemotherapy|May 22, 2024
NPP-669, a prodrug of cidofovir, is highly efficacious against human adenovirus infection in the permissive Syrian hamster modelAnn E Tollefson, Anna B Cline-Smith, Jacqueline F Spencer, et al.
Pageof 5